Novo Nordisk Foundation
Center for Basic Metabolic Research

News - Schwartz Group

“Working in a small company where I get insights into everything is fantastic”

Sofie Liljewall is an industrial PhD Student at SOLID Therapeutics and CBMR. Sofie has a Master’s degree in molecular biotechnology engineering and did her Master's thesis in the Schwartz Group at CBMR.

Professor Thue W. Schwartz wins UCPH Innovation Prize 2023

A founding member of CBMR, Professor Thue W. Schwartz is a pioneering fundamental researcher and co-founder of countless spinouts who has won this year's UCPH Innovation Prize.

Novo Nordisk buys CBMR biotech spinout to acquire their novel approach for treating obesity and type 2 diabetes

Researchers from University of Copenhagen discovered a target that suppresses hunger, stimulates calorie burning and increases insulin sensitivity. The spinout Embark Biotech has now been acquired by Novo Nordisk

Research spin outs

Two CBMR Group Leaders join the BioInnovation Institute’s Venture Lab program

Scientists at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) study metabolic health and disease in the hope that their discoveries will lead to new prevention and treatment strategies.

A Cellular Call for Help

When succinate is released by cells in distress it activates nearby white blood cells, and surprisingly promotes their protective, anti-inflammatory power.

Research translation

CBMR scientists win innovation funding to develop new anti-cancer and obesity drugs

The BioInnovation Institute (BII) has awarded two grants worth DKK 3.5M each to CBMR to develop new drugs based on its basic metabolic research.